Responses
Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
1 Nilogen Oncosystem’s 3D-EXpress platform allows rapid assessment of mono and combo targeted and immune therapies using a biorepository of fresh patient tumoroids with intact tumor microenvironment
Compose a Response to This Article
Other responses
No responses have been published for this article.